AGIO
Price
$23.14
Change
+$0.59 (+2.62%)
Updated
Dec 7, 6:59 PM EST
69 days until earnings call
CRSP
Price
$70.21
Change
-$0.93 (-1.31%)
Updated
Dec 7, 6:59 PM EST
67 days until earnings call
Ad is loading...

Analysis and predictions AGIO vs CRSP

Header iconAGIO vs CRSP Comparison
Open Charts AGIO vs CRSPBanner chart's image
Agios Pharmaceuticals
Price$23.14
Change+$0.59 (+2.62%)
Volume$224.49K
CapitalizationN/A
CRISPR Therapeutics AG
Price$70.21
Change-$0.93 (-1.31%)
Volume$1.15M
CapitalizationN/A
View a ticker or compare two or three
AGIO vs CRSP Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
AGIO vs. CRSP commentary
Dec 08, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGIO is a StrongBuy and CRSP is a Hold.

COMPARISON
Comparison
Dec 08, 2023
Stock price -- (AGIO: $23.12 vs. CRSP: $70.18)
Brand notoriety: AGIO and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGIO: 50% vs. CRSP: 95%
Market capitalization -- AGIO: $1.21B vs. CRSP: $5.69B
AGIO [@Biotechnology] is valued at $1.21B. CRSP’s [@Biotechnology] market capitalization is $5.69B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGIO’s FA Score shows that 0 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • AGIO’s FA Score: 0 green, 5 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, both AGIO and CRSP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGIO’s TA Score shows that 5 TA indicator(s) are bullish.

  • AGIO’s TA Score: 5 bullish, 4 bearish.

Price Growth

AGIO (@Biotechnology) experienced а +4.00% price change this week, while CRSP (@Biotechnology) price change was +5.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10152.36%. For the same industry, the average monthly price growth was +6.66%, and the average quarterly price growth was +25.39%.

Reported Earning Dates

AGIO is expected to report earnings on Feb 15, 2024.

CRSP is expected to report earnings on Feb 13, 2024.

Industries' Descriptions

@Biotechnology (+10152.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for AGIO with price predictions.
OPEN
A.I.dvisor published
a Summary for CRSP with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CRSP($5.69B) has a higher market cap than AGIO($1.21B). CRSP YTD gains are higher at: 72.645 vs. AGIO (-17.664). AGIO has higher annual earnings (EBITDA): -377.35M vs. CRSP (-402.88M). CRSP has more cash in the bank: 1.74B vs. AGIO (647M). AGIO has less debt than CRSP: AGIO (75.5M) vs CRSP (242M). CRSP has higher revenues than AGIO: CRSP (170M) vs AGIO (24M).
AGIOCRSPAGIO / CRSP
Capitalization1.21B5.69B21%
EBITDA-377.35M-402.88M94%
Gain YTD-17.66472.645-24%
P/E RatioN/A20.92-
Revenue24M170M14%
Total Cash647M1.74B37%
Total Debt75.5M242M31%
FUNDAMENTALS RATINGS
AGIO vs CRSP: Fundamental Ratings
AGIO
CRSP
OUTLOOK RATING
1..100
1970
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
68
Overvalued
PROFIT vs RISK RATING
1..100
10073
SMR RATING
1..100
9594
PRICE GROWTH RATING
1..100
6937
P/E GROWTH RATING
1..100
10075
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AGIO's Valuation (42) in the Biotechnology industry is in the same range as CRSP (68). This means that AGIO’s stock grew similarly to CRSP’s over the last 12 months.

CRSP's Profit vs Risk Rating (73) in the Biotechnology industry is in the same range as AGIO (100). This means that CRSP’s stock grew similarly to AGIO’s over the last 12 months.

CRSP's SMR Rating (94) in the Biotechnology industry is in the same range as AGIO (95). This means that CRSP’s stock grew similarly to AGIO’s over the last 12 months.

CRSP's Price Growth Rating (37) in the Biotechnology industry is in the same range as AGIO (69). This means that CRSP’s stock grew similarly to AGIO’s over the last 12 months.

CRSP's P/E Growth Rating (75) in the Biotechnology industry is in the same range as AGIO (100). This means that CRSP’s stock grew similarly to AGIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGIO
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
75%
Momentum
ODDS (%)
Bullish Trend 1 day ago
74%
MACD
ODDS (%)
Bullish Trend 4 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 1 day ago
72%
Declines
ODDS (%)
Bearish Trend 28 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
Aroon
ODDS (%)
Bearish Trend 1 day ago
79%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBDIX114.441.46
+1.29%
Franklin Biotechnology Discovery A
PGRNX20.940.11
+0.53%
Impax Global Environmental Markets Inv
GCPNX16.700.07
+0.42%
Gateway Equity Call Premium N
PMBPX36.530.14
+0.38%
Principal MidCap R5
BRKCX11.95-0.01
-0.08%
MFS Blended Research Em Mkts Eq C

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with BEAM. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
-1.35%
BEAM - CRSP
73%
Closely correlated
+0.28%
NTLA - CRSP
71%
Closely correlated
-0.27%
EDIT - CRSP
65%
Loosely correlated
-1.94%
DNLI - CRSP
62%
Loosely correlated
-2.09%
VERV - CRSP
61%
Loosely correlated
+3.20%
More